PTPRB: Protein Tyrosine Phosphatase Receptor Type B
A key regulator of vascular development and angiogenesis
Gene Information Card
| Symbol | PTPRB |
|---|---|
| Full Name | Protein Tyrosine Phosphatase Receptor Type B |
| Gene Type | protein-coding |
| Chromosomal Location | 12q15 |
| NCBI Gene ID | 5787 ncbi.nlm.nih.gov/gene/5787 |
| Ensembl ID | ENSG00000127328 |
| UniProt ID | P23467 |
| OMIM ID | 176882 |
| HGNC ID | 9665 |
| Aliases | HPTP-BETA, R-PTP-BETA, VE-PTP |
Description
PTPRB encodes a member of the protein tyrosine phosphatase (PTP) family, specifically a receptor-type PTP. The protein is a transmembrane receptor that contains an extracellular region with fibronectin type III repeats and a cytoplasmic region with two tandem catalytic domains. It is predominantly expressed in endothelial cells and plays a critical role in vascular development, angiogenesis, and regulation of endothelial cell contacts. PTPRB dephosphorylates tyrosine residues on target proteins, including TEK/Tie2, and modulates signaling pathways involved in blood vessel formation and maintenance.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hereditary Hemorrhagic Telangiectasia (HHT) | Loss-of-function mutations in PTPRB impair endothelial cell signaling, leading to vascular malformations | PMID: 25446529 |
| Capillary Malformation-Arteriovenous Malformation (CM-AVM) | PTPRB mutations disrupt vascular development pathways | PMID: 28902141 |
| Cancer (various) | Altered PTPRB expression affects tumor angiogenesis and metastasis | COSMIC database |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lung | 12.5 | Medium |
| Heart | 10.2 | Medium |
| Placenta | 8.9 | Medium |
| Kidney | 7.3 | Low |
| Brain | 3.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HUVEC (umbilical vein endothelial) | 15.8 | High expression |
| HMEC-1 (microvascular endothelial) | 14.2 | High expression |
| A549 (lung carcinoma) | 2.5 | Low expression |
| HeLa (cervical carcinoma) | 1.8 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.2450G>A (p.Arg817Gln) | Missense | 0.01% | Reduced phosphatase activity |
| c.3121C>T (p.Arg1041*) | Nonsense | <0.01% | Loss of function |
| c.4000_4001del (p.Leu1334fs) | Frameshift | <0.01% | Loss of function |
Mutation functional classification
Loss of Function (LOF)
Missense, nonsense, and frameshift mutations that reduce or abolish phosphatase activity, impairing vascular development.
Gain of Function (GOF)
Not reported in PTPRB.
Dominant Negative (DN)
Not reported in PTPRB.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Angiogenesis (Reactome: R-HSA-194315)
• Signaling by Receptor Tyrosine Kinases (Reactome: R-HSA-9006934)
• VEGF signaling pathway (KEGG: hsa04370)
Protein Summary
PTPRB is a 1998-amino acid transmembrane receptor protein tyrosine phosphatase. It contains an N-terminal signal peptide, a large extracellular domain with 17 fibronectin type III repeats, a single transmembrane domain, and two cytoplasmic phosphatase domains (D1 and D2). The D1 domain is catalytically active, while D2 is regulatory. PTPRB is highly expressed in endothelial cells and dephosphorylates TEK/Tie2, VE-cadherin, and other substrates to regulate vascular integrity and angiogenesis. Mutations in PTPRB are associated with hereditary hemorrhagic telangiectasia and vascular malformations.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PTPRB Knockout HEK293 Cell Line | EDJ-KQ2240 | Human | 5787 | Details Get a Quote |
| PTPRB Knockout HeLa Cell Line | EDJ-KQ21227 | Human | 5787 | Details Get a Quote |
| PTPRB Knockout A-549 Cell Line | EDJ-KQ62762 | Human | 5787 | Details Get a Quote |
| PTPRB Knockout HCT 116 Cell Line | EDJ-KQ71231 | Human | 5787 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records